0,660  0,037  Apoptosis agonist
0,608  0,012  Immunosuppressant
0,551  0,020  CYP2C19 substrate
0,529  0,015  FMO1 substrate
0,518  0,004  Pneumotoxic
0,479  0,008  Septic shock treatment
0,480  0,012  Sedative
0,480  0,016  Tumour necrosis factor alpha release inhibitor
0,466  0,005  Acaricide
0,467  0,006  Antiacne
0,475  0,014  Antimitotic
0,496  0,048  TNF expression inhibitor
0,489  0,043  GST A substrate
0,425  0,013  UGT1A4 substrate
0,441  0,030  Analeptic
0,454  0,048  Antipruritic, allergic
0,432  0,033  Antipsoriatic
0,428  0,030  Chemoprotective
0,425  0,027  Cardiovascular analeptic
0,441  0,045  GABA C receptor rho-3 antagonist
0,427  0,030  ICAM1 expression inhibitor
0,452  0,056  Antibacterial
0,447  0,063  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,401  0,016  Skin irritative effect
0,417  0,040  Antifungal
0,402  0,032  NOS2 expression inhibitor
0,384  0,017  5 Hydroxytryptamine uptake stimulant
0,421  0,057  Antileukemic
0,446  0,085  Caspase 9 stimulant
0,397  0,045  Respiratory analeptic
0,409  0,060  CYP2C9 substrate
0,370  0,024  Interleukin agonist
0,380  0,036  Sensitization
0,366  0,022  Abortion inducer
0,425  0,081  Alzheimer's disease treatment
0,405  0,067  Antiprotozoal
0,366  0,030  Antineoplastic (liver cancer)
0,355  0,022  GST M1-1 substrate
0,342  0,022  Platelet adhesion inhibitor
0,352  0,036  Mutagenic
0,360  0,046  Antiosteoporotic
0,361  0,048  Antiepileptic
0,360  0,048  CYP1A2 substrate
0,322  0,014  Alpha-N-acetylglucosaminidase inhibitor
0,334  0,026  RNA-directed DNA polymerase inhibitor
0,325  0,018  Antialcoholic
0,357  0,050  Teratogen
0,341  0,035  Acute neurologic disorders treatment
0,426  0,124  Antiinflammatory
0,362  0,061  Bone diseases treatment
0,354  0,055  5 Hydroxytryptamine release stimulant
0,327  0,029  Antiparkinsonian, rigidity relieving
0,315  0,019  Carcinogenic, group 3
0,343  0,050  Embryotoxic
0,330  0,039  Angiogenesis stimulant
0,369  0,079  Atherosclerosis treatment
0,313  0,024  UGT2B7 substrate
0,342  0,052  CTGF expression inhibitor
0,329  0,041  Carcinogenic
0,329  0,041  Myocardial infarction treatment
0,289  0,005  Vanilloid agonist
0,281  0,009  Ferrochelatase inhibitor
0,319  0,048  Cytotoxic
0,322  0,051  FMO3 substrate
0,302  0,032  UGT1A1 substrate
0,351  0,082  Ulceration
0,275  0,008  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,324  0,058  Interleukin 2 agonist
0,306  0,041  Psychostimulant
0,298  0,034  Tyrosine 3 hydroxylase inhibitor
0,364  0,104  5 Hydroxytryptamine release inhibitor
0,351  0,097  Antineoplastic (breast cancer)
0,308  0,058  UGT2B4 substrate
0,261  0,011  ATPase inhibitor
0,260  0,010  Farnesoid X receptor antagonist
0,321  0,072  Calcium channel activator
0,309  0,060  Antineoplastic (multiple myeloma)
0,284  0,036  Antihypotensive
0,290  0,043  Anticonvulsant
0,290  0,047  DNA synthesis inhibitor
0,285  0,043  Nitric oxide antagonist
0,284  0,045  Chemopreventive
0,267  0,029  CYP2B6 inhibitor
0,243  0,010  Microtubule formation inhibitor
0,251  0,020  UGT2B9 substrate
0,279  0,049  Antiparasitic
0,260  0,031  Antipruritic, non-allergic
0,246  0,018  Antifungal enhancer
0,263  0,038  Non-steroidal antiinflammatory agent
0,264  0,039  VCAM1 expression inhibitor
0,283  0,058  Proliferative diseases treatment
0,265  0,040  Antihelmintic
0,247  0,026  CNS active muscle relaxant
0,228  0,007  TRPA1 agonist
0,226  0,009  GABA C receptor antagonist
0,243  0,028  Protein kinase stimulant
0,306  0,091  Transcription factor NF kappa B inhibitor
0,219  0,004  GST T1-1 substrate
0,214  0,002  ATPase (Vacuolar H+) inhibitor
0,241  0,030  Interferon gamma antagonist
0,237  0,027  Succinate dehydrogenase inhibitor
0,279  0,070  Antioxidant
0,228  0,021  SULT1A3 substrate
0,275  0,067  Flavin-containing monooxygenase substrate
0,281  0,078  Antineoplastic (melanoma)
0,276  0,073  Aldehyde oxidase inhibitor
0,233  0,031  Melanin inhibitor
0,212  0,015  Alcohol dehydrogenase substrate
0,234  0,039  Antianorexic
0,256  0,064  Cytostatic
0,224  0,033  5 Hydroxytryptamine 3E antagonist
0,282  0,091  CYP2D6 substrate
0,255  0,066  Antiglaucomic
0,239  0,051  Antiviral (Influenza)
0,207  0,020  Antineoplastic antibiotic
0,219  0,035  Antiviral (Influenza A)
0,204  0,020  GABA C receptor agonist
0,212  0,029  UGT2B10 substrate
0,299  0,116  CYP2C9 inhibitor
0,185  0,003  Kainate receptor 5 antagonist
0,287  0,107  CYP3A4 substrate
0,204  0,029  Arachidonic acid antagonist
0,261  0,086  Antineoplastic (pancreatic cancer)
0,214  0,044  Antihelmintic (Nematodes)
0,185  0,016  Aldehyde dehydrogenase substrate
0,177  0,008  Ca2+-transporting ATPase inhibitor
0,285  0,116  Stroke treatment
0,176  0,008  Antidote, mercury
0,173  0,007  Ornithine decarboxylase inhibitor
0,268  0,103  AR expression inhibitor
0,214  0,049  Antimutagenic
0,271  0,110  Antithrombotic
0,197  0,036  Carcinogenic, group 1
0,198  0,041  Antirickettsial
0,205  0,049  Eye irritation, high
0,178  0,026  Expectorant
0,189  0,040  Antiseptic
0,214  0,067  Nitric-oxide synthase stimulant
0,162  0,017  GABA C receptor rho-1 antagonist
0,192  0,047  Neuropathy treatment
0,316  0,172  Antineoplastic (solid tumors)
0,190  0,047  UGT2B15 substrate
0,176  0,033  Movement disorders treatment
0,260  0,118  Cholesterol antagonist
0,160  0,018  Actinic keratosis treatment
0,180  0,040  Histone deacetylase SIRT1 inhibitor
0,188  0,048  Phobic disorders treatment
0,168  0,030  Excitatory amino acid transporter EAAC1 inhibitor
0,202  0,064  Hepatoprotectant
0,164  0,027  Vanilloid 1 agonist
0,156  0,019  Porphobilinogen synthase inhibitor
0,152  0,016  CYP2A6 inhibitor
0,151  0,017  Anabolic
0,271  0,140  Histamine release inhibitor
0,192  0,061  Peroxidase inhibitor
0,159  0,029  Choleretic
0,171  0,042  Cholinergic antagonist
0,167  0,038  Adenylate cyclase stimulant
0,139  0,011  Biliverdin reductase inhibitor
0,168  0,041  Acetylcholine antagonist
0,174  0,047  GABA C receptor rho-2 antagonist
0,130  0,003  Kainate receptor 3 antagonist
0,153  0,028  UDP-glucose 4-epimerase inhibitor
0,155  0,033  SULT1A1 substrate
0,186  0,064  Muscle relaxant
0,150  0,032  Mucolytic
0,227  0,109  Gastrin inhibitor
0,227  0,109  CYP1A2 inhibitor
0,232  0,115  Antihypoxic
0,144  0,028  Transcription factor STAT6 inhibitor
0,125  0,011  Human rhinovirus A protease inhibitor
0,162  0,048  Hearing loss treatment
0,219  0,106  Spasmolytic
0,212  0,099  Antipyretic
0,137  0,026  Carcinogenic, group 2A
0,138  0,027  Antiprotozoal (Toxoplasma)
0,163  0,054  Cell wall synthesis inhibitor
0,168  0,060  Acetylcholine M1 receptor antagonist
0,132  0,025  UGT2B11 substrate
0,137  0,030  Creatine kinase inhibitor
0,142  0,036  Photosensitizer
0,115  0,009  Vanilloid 4 agonist
0,132  0,026  Triose-phosphate isomerase inhibitor
0,107  0,003  Microtubule stabilization
0,106  0,002  Tubulin agonist
0,161  0,058  Contraceptive
0,182  0,082  UDP-glucuronosyltransferase substrate
0,205  0,106  Antiviral (West Nile virus)
0,187  0,090  Neurotrophic factor enhancer
0,123  0,026  Antifungal (Aspergillus)
0,101  0,005  Anesthetic inhalation
0,106  0,011  Antidote, organophosphates
0,112  0,017  T cell inhibitor
0,120  0,025  Inducible nitric-oxide synthase inhibitor
0,142  0,047  Coagulant
0,241  0,148  Antiprotozoal (Plasmodium)
0,209  0,116  UGT1A9 substrate
0,231  0,138  Antineoplastic (lung cancer)
0,133  0,040  Antihelmintic (Fasciola)
0,133  0,040  GST P1-1 substrate
0,213  0,121  Transcription factor STAT inhibitor
0,119  0,027  Antibiotic
0,119  0,029  NADH dehydrogenase inhibitor
0,120  0,030  Acetylcholine nicotinic antagonist
0,144  0,054  Retinoprotector
0,107  0,017  Glycine receptor agonist
0,191  0,102  UGT1A6 substrate
0,135  0,046  Antiprotozoal (Babesia)
0,111  0,023  NAT1 substrate
0,193  0,105  Antiprotozoal (Leishmania)
0,090  0,004  Retinoic acid alpha receptor agonist
0,149  0,065  Mannose-6-phosphate isomerase inhibitor
0,108  0,024  Na+ K+ transporting ATPase inhibitor
0,192  0,109  Antihypercholesterolemic
0,109  0,026  Keratolytic
0,118  0,037  Posttraumatic stress disorder treatment
0,114  0,034  Antithrombocytopenic
0,164  0,084  Tumour necrosis factor antagonist
0,137  0,057  Antismoking
0,089  0,009  Postcoital contraceptive
0,166  0,090  LDLR expression enhancer
0,127  0,050  Antifungal (Pneumocystis)
0,120  0,044  Adenylate kinase inhibitor
0,134  0,058  Aldehyde dehydrogenase inhibitor
0,079  0,004  Kainate receptor agonist
0,101  0,026  GABA aminotransferase inhibitor
0,196  0,122  Superoxide dismutase inhibitor
0,103  0,029  Glycine receptor antagonist
0,146  0,073  Genotoxic
0,103  0,029  Glutamate dehydrogenase inhibitor
0,194  0,121  DNA damaging
0,145  0,072  Hair growth stimulant
0,084  0,012  5-Alpha-reductase inhibitor
0,247  0,175  CYP2C19 inhibitor
0,091  0,020  Alcohol oxidase inhibitor
0,130  0,059  Alkylator
0,129  0,059  Growth stimulant
0,078  0,008  Retinoid X receptor agonist
0,102  0,033  Granulocyte macrophage colony stimulating factor agonist
0,110  0,041  Lanosterol 14 alpha demethylase inhibitor
0,082  0,013  Calcium channel P-type blocker
0,111  0,043  Tourette's syndrome treatment
0,188  0,120  Antineoplastic (renal cancer)
0,081  0,013  Aconitate hydratase inhibitor
0,086  0,019  Glutamate (mGluR6) antagonist
0,075  0,009  Pregnane X receptor antagonist
0,098  0,033  Nicotinic alpha4beta2 receptor antagonist
0,150  0,086  Uterine stimulant
0,083  0,021  SULT2A1 substrate
0,116  0,054  NAT2 substrate
0,101  0,040  Interleukin 5 antagonist
0,109  0,047  Nitric-oxide synthase inhibitor
0,191  0,130  Radioprotector
0,074  0,015  Nicotinic alpha3beta2 receptor antagonist
0,103  0,045  Androgen antagonist
0,112  0,055  DOPA decarboxylase inhibitor
0,062  0,005  Vanilloid 3 antagonist
0,113  0,055  Antiviral (Poxvirus)
0,120  0,064  Protein-tyrosine phosphatase 1B inhibitor
0,090  0,034  Narcotic antagonist
0,231  0,176  Antineoplastic (endocrine cancer)
0,092  0,037  Estrogen-related receptor beta agonist
0,195  0,141  Transcription factor STAT3 inhibitor
0,112  0,059  Carcinogenic, group 2B
0,121  0,068  Contraceptive female
0,124  0,071  Cathepsin H inhibitor
0,063  0,010  Retinoid X alpha receptor agonist
0,055  0,003  Vanilloid 2 agonist
0,058  0,007  Retinoid X receptor antagonist
0,145  0,094  Prostate disorders treatment
0,087  0,037  Phosphofructokinase-1 inhibitor
0,117  0,068  Cholesterol synthesis inhibitor
0,073  0,025  Estrogen agonist
0,086  0,037  Aminopeptidase I inhibitor
0,180  0,133  Immunostimulant
0,053  0,005  Retinoic acid receptor agonist
0,051  0,003  Progesterone receptor B antagonist
0,099  0,052  ABCA1 expression enhancer
0,119  0,073  Sphingosine 1-phosphate receptor 4 antagonist
0,055  0,009  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,100  0,055  Prolactin inhibitor
0,051  0,006  Retinoid X alpha receptor antagonist
0,069  0,024  Cannabinoid CB2 receptor antagonist
0,218  0,173  Calpain 2 inhibitor
0,068  0,024  Dopamine D4 agonist
0,075  0,031  Carbamoyl phosphate synthetase inhibitor
0,048  0,005  Adenosine uptake inhibitor
0,070  0,027  Acyl-CoA dehydrogenase inhibitor
0,128  0,085  Antiparkinsonian, tremor relieving
0,150  0,107  Phospholipase C inhibitor
0,055  0,012  GABA uptake inhibitor
0,109  0,067  Cystathionine beta-synthase inhibitor
0,057  0,015  Estrogen receptor alpha agonist
0,120  0,079  Antihyperlipoproteinemic
0,047  0,006  Retinoid X gamma receptor agonist
0,045  0,004  Retinoic acid beta receptor agonist
0,044  0,004  Retinoic acid gamma receptor agonist
0,108  0,067  5 Hydroxytryptamine 3A agonist
0,067  0,028  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,059  0,019  Glucose-6-phosphate isomerase inhibitor
0,162  0,123  Antineoplastic (glioma)
0,098  0,060  Electrolyte absorption antagonist
0,102  0,064  Aminopeptidase B inhibitor
0,111  0,074  Anesthetic local
0,068  0,031  Argininosuccinate synthase inhibitor
0,095  0,058  Antiviral (Rhinovirus)
0,064  0,028  Ryanodine receptor antagonist
0,076  0,041  Phospholipase D inhibitor
0,075  0,039  Acetylcholine M5 receptor agonist
0,081  0,046  Acetylcholine M4 receptor antagonist
0,164  0,130  VEGF expression inhibitor
0,069  0,036  Cannabinoid CB1 receptor antagonist
0,114  0,081  Antiviral (Influenza B)
0,054  0,021  Cytokine production stimulant
0,040  0,008  5-Alpha-reductase 1 inhibitor
0,100  0,068  Glutathione S-transferase substrate
0,037  0,005  Retinoid X gamma receptor antagonist
0,073  0,041  Anticholelithogenic
0,076  0,045  S-adenosyl-L-methionine decarboxylase inhibitor
0,100  0,071  UGT2B1 substrate
0,067  0,037  Antiviral (Parainfluenza)
0,071  0,041  Glutamate (mGluR7) antagonist
0,048  0,019  Dopamine D5 agonist
0,059  0,030  Dihydroorotate oxidase inhibitor
0,035  0,007  Retinoid X beta receptor agonist
0,049  0,022  Guanylate cyclase inhibitor
0,135  0,107  CF transmembrane conductance regulator agonist
0,084  0,057  Antispirochetal
0,070  0,043  Exportin-1 inhibitor
0,075  0,049  Glutamate decarboxylase inhibitor
0,145  0,119  Anesthetic general
0,031  0,005  Retinoic acid receptor antagonist
0,065  0,039  Transcription factor RelA inhibitor
0,082  0,056  Thioredoxin reductase inhibitor
0,057  0,032  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,057  0,032  Nicotinic receptor alpha7 subunit antagonist
0,048  0,023  Glutamate (mGluR group III) antagonist
0,029  0,005  Retinoid X beta receptor antagonist
0,082  0,058  CC chemokine 5 receptor agonist
0,045  0,021  3-Hydroxyanthranilate 3,4-dioxygenase inhibitor
0,044  0,020  TRPM8 blocker
0,124  0,101  Antidote
0,047  0,024  Glutamate (mGluR4) antagonist
0,124  0,101  Skeletal muscle relaxant
0,029  0,007  Retinoic acid alpha receptor antagonist
0,063  0,041  Antimycoplasmal
0,067  0,045  Bcl2 antagonist
0,062  0,042  Transcription factor AP-1 inhibitor
0,091  0,071  Bile acid receptor antagonist
0,065  0,046  Hypercalcemia treatment
0,064  0,045  Hyperparathyroidism treatment
0,087  0,069  Glutamate release inhibitor
0,046  0,028  Parathyroid hormone antagonist
0,104  0,086  Acetylcholine muscarinic antagonist
0,109  0,092  Anesthetic
0,176  0,158  5 Hydroxytryptamine 1E antagonist
0,069  0,051  Cannabinoid receptor antagonist
0,049  0,032  Dopamine beta hydroxylase inhibitor
0,047  0,030  Adenylate cyclase 1 inhibitor
0,030  0,013  Nicotinic acid receptor 2 antagonist
0,022  0,008  Alpha 2b adrenoreceptor agonist
0,032  0,018  Nicotinic alpha3beta4 receptor agonist
0,039  0,026  Alpha 1d adrenoreceptor agonist
0,061  0,049  CDC25B inhibitor
0,038  0,026  Glutamate (mGluR8) agonist
0,083  0,071  Antineoplastic, alkylator
0,137  0,126  3C-like protease (Human coronavirus) inhibitor
0,026  0,015  Glutamate (mGluR1) agonist
0,050  0,040  Protein 50S ribosomal subunit inhibitor
0,063  0,053  Potassium channel (ATP-sensitive) blocker
0,122  0,112  UGT1A3 substrate
0,046  0,035  Glutamate (mGluR group I) agonist
0,062  0,052  Neuronal nicotinic receptor antagonist
0,014  0,005  Calcineurin inhibitor
0,103  0,094  Retinopathy treatment
0,051  0,042  Alpha-mannosidase inhibitor
0,013  0,004  Progesterone receptor A antagonist
0,018  0,010  Telomerase stimulant
0,056  0,047  Androgen agonist
0,032  0,025  Sodium-dependent vitamin C transporter 2 inhibitor
0,056  0,049  Acetylcholine M5 receptor antagonist
0,056  0,049  Purinergic P2X1 antagonist
0,058  0,052  Dopamine D1 antagonist
0,070  0,064  Potassium channel (Tandem pore domain) blocker
0,152  0,146  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,019  0,014  5-Alpha-reductase 2 inhibitor
0,030  0,025  ATP citrate lysase inhibitor
0,188  0,183  Antineoplastic (brain cancer)
0,032  0,027  Fumarate hydratase inhibitor
0,123  0,118  Antifungal (Cryptococcus)
0,115  0,110  Sphingosine 1-phosphate receptor 2 antagonist
0,099  0,094  Interleukin 2 antagonist
0,029  0,024  Endothelial nitric-oxide synthase inhibitor
0,064  0,060  Benzodiazepine agonist
0,012  0,008  Retinoic acid receptor gamma antagonist
0,028  0,024  Estrogen receptor beta agonist
0,021  0,018  CYP24 inhibitor
0,019  0,016  Imidazoline I1 receptor antagonist
0,097  0,094  Beta amyloid protein antagonist
0,089  0,086  Antifungal (Candida)
0,052  0,050  Cannabinoid CB1 receptor agonist
0,015  0,012  Sodium/hydrogen exchanger 2 inhibitor
0,036  0,033  Kainate receptor antagonist
0,018  0,017  Antibiotic Anthracycline-like
0,020  0,019  Vitamin D receptor antagonist
0,004  0,003  Vitamin D-like
0,020  0,019  Glutamate (mGluR1a) agonist
0,035  0,035  Membrane dipeptidase inhibitor
0,049  0,049  Aromatase inhibitor

